BioSpace News Archive

With the rise in hospital acquired infections and rising awareness regarding the prevention of viruses the bio contamination market is expected to grow leaps and bounds during the forecast period.

Dengue is a mosquito-borne viral infectious disease affecting humans as well as animals, It is caused by the dengue virus, which belongs to the flaviviridae family and genus flavivirus.

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the VENTANA PD-L1 (SP263) Assay is available in countries accepting the CE mark as a companion diagnostic to identify non-small cell lung cancer (NSCLC) patients eligible for treatment with Libtayo® (cemiplimab), a PD-1 inhibitor therapy developed by Regeneron.

By the time you test positive for COVID-19, the SARS-CoV-2 virus has already taken up residence in your respiratory system.

Atreca, Inc. announced that it will present at the following upcoming investor conferences.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today the introduction of GuardantINFINITY™, a next-generation liquid biopsy that provides new, multi-dimensional insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development.

Antibe Therapeutics Inc. is pleased to announce the results of its annual meeting of shareholders held earlier.